Published in J Clin Invest on September 01, 1994
Exposure to recurrent sleep restriction in the setting of high caloric intake and physical inactivity results in increased insulin resistance and reduced glucose tolerance. J Clin Endocrinol Metab (2009) 2.16
Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest (1995) 1.70
Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. J Clin Invest (1996) 1.45
Evidence for pancreatic beta-cell dysfunction in brothers of women with polycystic ovary syndrome. Metabolism (2008) 1.20
Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands. J Clin Invest (1998) 1.00
Glycaemic regulation and insulin secretion are abnormal in cystic fibrosis pigs despite sparing of islet cell mass. Clin Sci (Lond) (2015) 0.94
Glucose effectiveness assessed under dynamic and steady state conditions. Comparability of uptake versus production components. J Clin Invest (1997) 0.87
Assessment of non-insulin-mediated glucose uptake: association with body fat and glycemic status. Metabolism (2010) 0.85
Cross-sectional and longitudinal changes of glucose effectiveness in relation to glucose tolerance: the insulin resistance atherosclerosis study. Diabetes Care (2011) 0.75
Proteomics of Skeletal Muscle: Focus on Insulin Resistance and Exercise Biology. Proteomes (2016) 0.75
Quantitative estimation of insulin sensitivity. Am J Physiol (1979) 7.37
Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med (1993) 6.89
Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol Respir Environ Exerc Physiol (1983) 6.45
Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet (1992) 6.28
Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes (1993) 5.70
Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med (1990) 4.87
The theoretical bases of indirect calorimetry: a review. Metabolism (1988) 4.12
Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes (1989) 3.79
Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am J Physiol (1988) 3.54
Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med (1989) 3.38
Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med (1993) 3.14
Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr (1985) 3.10
Europium as a label in time-resolved immunofluorometric assays. Anal Biochem (1984) 3.01
Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest (1987) 2.81
Banting lecture 1990. Beta-cells in type II diabetes mellitus. Diabetes (1991) 2.45
Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl J Med (1988) 2.43
Exercise induces recruitment of the "insulin-responsive glucose transporter". Evidence for distinct intracellular insulin- and exercise-recruitable transporter pools in skeletal muscle. J Biol Chem (1990) 2.27
Increased insulin concentrations in nondiabetic offspring of diabetic parents. N Engl J Med (1988) 2.06
Insulin-induced translocation of glucose transporters in rat hindlimb muscles. FEBS Lett (1987) 2.00
Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest (1992) 1.96
Identification of an intracellular pool of glucose transporters from basal and insulin-stimulated rat skeletal muscle. J Biol Chem (1990) 1.77
Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J Clin Endocrinol Metab (1990) 1.71
Quantitative estimation of beta cell sensitivity to glucose in the intact organism: a minimal model of insulin kinetics in the dog. Diabetes (1980) 1.67
Beta-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type 2 diabetes. Lancet (1986) 1.61
The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes (1992) 1.60
Diurnal variation in glucose tolerance. Cyclic suppression of insulin action and insulin secretion in normal-weight, but not obese, subjects. Diabetes (1992) 1.56
Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab (1987) 1.40
Rates of noninsulin-mediated glucose uptake are elevated in type II diabetic subjects. J Clin Invest (1985) 1.32
Expression of insulin regulatable glucose transporters in skeletal muscle from type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1990) 1.30
The insulin sensitivity index in nondiabetic man. Correlation between clamp-derived and IVGTT-derived values. Diabetes (1986) 1.30
Impaired activation of glycogen synthase in people at increased risk for developing NIDDM. Diabetes (1992) 1.18
Glucose transport and NIDDM. Diabetes Care (1992) 1.17
The contribution of insulin-dependent and insulin-independent glucose uptake to intravenous glucose tolerance in healthy human subjects. Diabetes (1994) 1.12
Estimation of insulin sensitivity and glucose clearance from minimal model: new insights from labeled IVGTT. Am J Physiol (1986) 1.09
Importance of glucose per se to intravenous glucose tolerance. Comparison of the minimal-model prediction with direct measurements. Diabetes (1985) 1.09
Insulin resistance in skeletal muscles in patients with NIDDM. Diabetes Care (1992) 1.05
Familial clustering of insulin sensitivity. Diabetes (1992) 1.04
Abnormal activation of glycogen synthesis in fibroblasts from NIDDM subjects. Evidence for an abnormality specific to glucose metabolism. Diabetes (1993) 1.03
Metabolic consequences of prolonged hyperinsulinemia in humans. Evidence for induction of insulin insensitivity. Diabetes (1986) 1.02
The effect of rate and dose of glucose infusion on the acute insulin response in man. J Clin Endocrinol Metab (1976) 1.00
Hyperglycaemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia (1992) 0.97
Relationship between the plasma insulin response to oral glucose and insulin-stimulated glucose utilization in normal subjects. Diabetes (1984) 0.94
Effects of epinephrine infusion on determinants of intravenous glucose tolerance in dogs. Am J Physiol (1988) 0.92
Insulin resistance and hypertriglyceridemia in nondiabetic relatives of patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1989) 0.90
Effects of prolonged pulsatile hyperinsulinemia in humans. Enhancement of insulin sensitivity. Diabetes (1990) 0.90
Metabolic effects of hyperglycemia and hyperinsulinemia on fate of intracellular glucose in NIDDM. Diabetes (1990) 0.89
The insulin sensitivity index. Correlation in dogs between values determined from the intravenous glucose tolerance test and the euglycemic glucose clamp. Diabetes (1984) 0.89
Metabolic abnormalities in children of non-insulin dependent diabetics. Br Med J (Clin Res Ed) (1986) 0.89
Pathogenic factors responsible for glucose intolerance in patients with NIDDM. Diabetes (1992) 0.88
Reproducibility of insulin sensitivity measured by the minimal model method. Diabetologia (1991) 0.88
Insulin and glucose levels and prevalence of glucose intolerance in pedigrees with multiple diabetic siblings. Diabetes (1991) 0.88
Islet function and insulin sensitivity in the non-diabetic offspring of conjugal type 2 diabetic patients. Diabet Med (1990) 0.87
Insulin sensitivity, glucose effectiveness, and body fat distribution pattern in nondiabetic offspring of patients with NIDDM. Diabetes Care (1991) 0.87
Fasting hyperglycemia normalizes oxidative and nonoxidative pathways of insulin-stimulated glucose metabolism in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1990) 0.86
Dyslipidemias among normoglycemic members of familial NIDDM pedigrees. Diabetes Care (1992) 0.85
Conversational SAAM--an interactive program for kinetic analysis of biological systems. Comput Programs Biomed (1981) 0.85
A modified minimal model analysis of insulin sensitivity and glucose-mediated glucose disposal in insulin-dependent diabetes. Metabolism (1991) 0.82
Elevated GLUT 1 level in crude muscle membranes from diabetic Zucker rats despite a normal GLUT 1 level in perineurial sheaths. Diabetologia (1994) 0.80
The first phase insulin response to intravenous glucose is highly reproducible. Diabetologia (1990) 0.80
Proportional proinsulin responses in first-degree relatives of patients with type 2 diabetes mellitus. Acta Diabetol (1993) 0.80
Decreased insulin sensitivity in offspring whose parents both have type 2 diabetes. Diabet Med (1990) 0.79
Decreased tyrosine kinase activity in partially purified insulin receptors from muscle of young, non-obese first degree relatives of patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia (1993) 0.79
Contribution of postprandial insulin and glucose to glucose disposal in normal and insulin-resistant obese subjects. J Clin Endocrinol Metab (1991) 0.78
Application of the SAAM modeling program to minimal model analysis of intravenous glucose tolerance test data. Comput Methods Programs Biomed (1990) 0.76
The effect of epinephrine on glucose-mediated and insulin-mediated glucose disposal in insulin-dependent diabetes. Metabolism (1992) 0.76
Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial. Diabetologia (2009) 4.81
Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance--a population-based twin study. Diabetologia (1999) 3.64
Insulin resistance as the major cause of impaired glucose tolerance: a self-fulfilling prophesy? Lancet (1994) 3.32
Randomised controlled trial of structured personal care of type 2 diabetes mellitus. BMJ (2001) 3.12
The epidemic of type 2 diabetes is a statistical artefact. Diabetologia (2005) 2.41
Low birth weight is associated with NIDDM in discordant monozygotic and dizygotic twin pairs. Diabetologia (1997) 2.41
Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins. BMJ (1995) 2.40
Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest (1992) 1.96
Genetic versus environmental aetiology of the metabolic syndrome among male and female twins. Diabetologia (2001) 1.65
Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance. Diabetologia (2010) 1.64
Pulsatile insulin has greater hypoglycemic effect than continuous delivery. Diabetes (1983) 1.61
Physical training increases muscle GLUT4 protein and mRNA in patients with NIDDM. Diabetes (1994) 1.59
Impaired insulin-induced site-specific phosphorylation of TBC1 domain family, member 4 (TBC1D4) in skeletal muscle of type 2 diabetes patients is restored by endurance exercise-training. Diabetologia (2010) 1.57
Effects of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase, and glycogen synthase. Evidence for their role in oxidative and nonoxidative glucose metabolism. J Clin Invest (1987) 1.56
Cardiovascular safety of combination therapies with incretin-based drugs and metformin compared with a combination of metformin and sulphonylurea in type 2 diabetes mellitus--a retrospective nationwide study. Diabetes Obes Metab (2014) 1.54
Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes (1996) 1.52
The new Danish Twin Register: establishment and analysis of twinning rates. Int J Epidemiol (1995) 1.50
Microbial decomposition of wood in streams: distribution of microflora and factors affecting [C]lignocellulose mineralization. Appl Environ Microbiol (1983) 1.50
Age influences DNA methylation and gene expression of COX7A1 in human skeletal muscle. Diabetologia (2008) 1.50
Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia (1991) 1.49
Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes? Diabetologia (2009) 1.48
Clinical impact of mild carbohydrate intolerance in pregnancy: a study of 2904 nondiabetic Danish women with risk factors for gestational diabetes mellitus. Am J Obstet Gynecol (2001) 1.47
Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1991) 1.47
Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism. J Clin Endocrinol Metab (1998) 1.46
Does zygosity influence the metabolic profile of twins? A population based cross sectional study. BMJ (1999) 1.46
GLUT4 is reduced in slow muscle fibers of type 2 diabetic patients: is insulin resistance in type 2 diabetes a slow, type 1 fiber disease? Diabetes (2001) 1.38
Independent influence of age on basal insulin secretion in nondiabetic humans. European Group for the Study of Insulin Resistance. J Clin Endocrinol Metab (1999) 1.37
Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus. J Clin Invest (1991) 1.36
Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action. Diabetologia (2008) 1.35
Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes. Diabetologia (2001) 1.34
Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency. Diabetes (1999) 1.31
Expression of insulin regulatable glucose transporters in skeletal muscle from type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1990) 1.30
Effects of short-term high-fat overfeeding on genome-wide DNA methylation in the skeletal muscle of healthy young men. Diabetologia (2012) 1.30
Type 2 diabetes risk alleles near ADCY5, CDKAL1 and HHEX-IDE are associated with reduced birthweight. Diabetologia (2010) 1.28
On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion. Diabetologia (1990) 1.26
Impaired cellular insulin binding and insulin sensitivity induced by high-fructose feeding in normal subjects. Am J Clin Nutr (1980) 1.24
Lumbar vertebral body compressive strength evaluated by dual-energy X-ray absorptiometry, quantitative computed tomography, and ashing. Bone (1999) 1.22
Decreased activation of skeletal muscle glycogen synthase by mixed-meal ingestion in NIDDM. Diabetes (1988) 1.21
Age-dependent impact of zygosity and birth weight on insulin secretion and insulin action in twins. Diabetologia (2002) 1.19
Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group. Diabetologia (1996) 1.17
Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. J Clin Invest (1995) 1.17
Sex differences in glucose levels: a consequence of physiology or methodological convenience? The Inter99 study. Diabetologia (2010) 1.16
A cellular model system of differentiated human myotubes. APMIS (2001) 1.15
GLUT 4 and insulin receptor binding and kinase activity in trained human muscle. J Physiol (1993) 1.14
Insulin resistance induced by physical inactivity is associated with multiple transcriptional changes in skeletal muscle in young men. Am J Physiol Endocrinol Metab (2010) 1.14
Classification of newly diagnosed diabetic patients as insulin-requiring or non-insulin-requiring based on clinical and biochemical variables. Diabetes Care (1989) 1.13
Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study. Diabetologia (2011) 1.13
No association between birth weight and Type 1 diabetes mellitus--a twin-control study. Diabet Med (2000) 1.11
Effect of physical training on mitochondrial respiration and reactive oxygen species release in skeletal muscle in patients with obesity and type 2 diabetes. Diabetologia (2010) 1.11
Low birthweight and premature birth are both associated with type 2 diabetes in a random sample of middle-aged Danes. Diabetologia (2010) 1.11
Pulsatile, synchronous basal insulin and glucagon secretion in man. Diabetes (1982) 1.10
Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocol. Diabetologia (2005) 1.09
Rosiglitazone RECORD study: glucose control outcomes at 18 months. Diabet Med (2007) 1.08
Maternal and perinatal outcomes in 143 Danish women with gestational diabetes mellitus and 143 controls with a similar risk profile. Diabet Med (2000) 1.08
Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy population. J Intern Med (2011) 1.07
Changes in patient weight and the impact of antidiabetic therapy during the first 5 years after diagnosis of diabetes mellitus. Diabetologia (2006) 1.06
Insulin resistance in skeletal muscles in patients with NIDDM. Diabetes Care (1992) 1.05
The pathogenic role of an insulin-receptor defect in diabetes mellitus of the obese. Diabetes (1978) 1.05
Effects of insulin on kidney function and sodium excretion in healthy subjects. Diabetologia (1989) 1.05
Chronic renal failure and growth. Arch Dis Child (1989) 1.05
Insulin receptor binding and receptor-mediated insulin degradation in human adipocytes. Diabetologia (1981) 1.04
Insulin-regulated mitochondrial gene expression is associated with glucose flux in human skeletal muscle. Diabetes (1999) 1.04
Correlations between insulin sensitivity and bone mineral density in non-diabetic men. Diabet Med (2000) 1.03
A reduced number of insulin receptors in patients with Prader-Willi syndrome. Acta Endocrinol (Copenh) (1983) 1.03
Effects of insulin on glucose turnover rates in vivo: isotope dilution versus constant specific activity technique. Metabolism (1996) 1.03
Assessment of hepatic insulin action in obese type 2 diabetic patients. Diabetes (2001) 1.03
Prevalence and mortality of acute myocardial infarction in patients with diabetes. Diabetes Care (1985) 1.03
No evidence of a higher 10 year period prevalence of diabetes among 77,885 twins compared with 215,264 singletons from the Danish birth cohorts 1910-1989. Diabetologia (2011) 1.02
Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study. J Bone Miner Res (2003) 1.02
Increased insulin receptors after exercise in patients with insulin-dependent diabetes mellitus. N Engl J Med (1980) 1.01
Insulin analogues and severe hypoglycaemia in type 1 diabetes. Diabetes Res Clin Pract (2011) 1.01
Direct evidence of fiber type-dependent GLUT-4 expression in human skeletal muscle. Am J Physiol Endocrinol Metab (2000) 1.01
Transcriptional profiling of myotubes from patients with type 2 diabetes: no evidence for a primary defect in oxidative phosphorylation genes. Diabetologia (2008) 1.00
A study of experimentally induced bovine viral diarrhea-mucosal disease in pregnant cows and their progeny. Cornell Vet (1969) 1.00
Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM. Diabetologia (1995) 1.00
Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women - results of the Danish Osteoporosis Prevention Study. Maturitas (2000) 1.00
Improved in vivo insulin effect during continuous subcutaneous insulin infusion in patients with IDDM. Diabetes (1984) 0.99
Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study. Diabetologia (2010) 0.99
Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial. Diabetes Obes Metab (2007) 0.98
Human ATP synthase beta is phosphorylated at multiple sites and shows abnormal phosphorylation at specific sites in insulin-resistant muscle. Diabetologia (2009) 0.98
Decreased binding of insulin to its receptor in patients with congenital generalized lipodystrophy. N Engl J Med (1977) 0.98
Insulin signal transduction in skeletal muscle from glucose-intolerant relatives of type 2 diabetic patients [corrected]. Diabetes (2001) 0.97
Hyperglycaemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia (1992) 0.97
Age- and gender-related differences in vertebral bone mass, density, and strength. J Bone Miner Res (1999) 0.97
C-peptide stimulates glucose transport in isolated human skeletal muscle independent of insulin receptor and tyrosine kinase activation. Diabetologia (1996) 0.96
Variation in absorption of NPH insulin due to intramuscular injection. Diabetes Care (1990) 0.96
Altered basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle from NIDDM patients compared with control subjects. Diabetologia (1996) 0.96